What’s Happening in Tobacco? Q1 2023

May 2023

This report examines the main news related to the tobacco industry for the first quarter of 2023. It covers key legislative announcements alongside prevalence surveys, mergers and acquisitions, company strategies, new product launches and other company initiatives. Macroeconomic uncertainty associated with high inflation and the war in Ukraine persist, while companies continue pursuing their strategic focus on reduced-risk products.

USD 1,325
Request More Information


This report comes in PPT.

Regulatory updates

Only a few e-vapour products authorised to be sold in the US market

The US Food and Drug Administration announced in March 2023 that over 99% of the nearly 26 million applications submitted from e-vapour product manufacturers had been revised and the agency had only authorised 23 tobacco flavoured e-vapour products and devices. The agency issued refuse to accept letters, refuse to file letters or marketing denial orders for all e-vapour products not authorised.

In accordance with the new federal law passed in April 2022, around 25 million e-vapour tobacco products and nearly one million e-vapour non-tobacco nicotine products were reviewed by the FDA since September 2020.

The FDA denies authorisation to Reynolds’ Vuse Solo menthol e-vapour products

In March 2023, the FDA issued a marketing denial order for two Reynolds’ Vuse Solo menthol e-vapour products. According to the agency, the Vuse Solo menthol refills do not meet the agency’s “appropriate for the protection of public health” standard because menthol e-cigarettes “have a known and substantial risk with regard to youth appeal, uptake and use”. The FDA has issued marketing denial orders for millions of flavoured e-liquids and pre-filled devices since the agency started the review of all e-vapour products existing in the US market in 2020.

Regulatory updates (1)
Regulatory updates (2)
Regulatory updates (3)
Regulatory updates (4)
Taxation updates (1)
Taxation updates (2)
Illicit trade updates (1)
Prevalence updates (1)
Market and product updates (1)
Market and product updates (2)
Market and product updates (3)
Market and product updates (4)
Market and product updates (5)
New product developments (1)
BAT FY results: Revenue growth driven by RRP expansion and combustible tobacco pricing
Philip Morris FY results: Smoke-free products reach a third of total revenues
JTI FY results: Core revenue increases driven by combustible pricing
Imperial Brands FY 2022: RRP revenue growth driven by new launches in Europe
Global baseline outlook: Global economy edges closer to recession amid sharp slowdown
Global inflation begins gradual downward trend – but remains significantly elevated in 2023
Real GDP annual growth forecasts and revisions from last quarter – AE
Real GDP annual growth forecasts and revisions from last quarter – EMDE
What to look for in Q2 2023


Passport Tobacco covers the seven major tobacco categories: Cigarettes, Cigars & Cigarillos, Smoking tobacco (made up of Pipe tobacco and RYO tobacco), Smokeless Tobacco (snuff and chewing tobacco), E-Vapour Products (closed and open); Heated Tobacco; and Tobacco Free Oral Nicotine. Smoking paraphernalia such as pipes, rolling papers, lighters or matches, etc., are not included, nor are nicotine replacement therapy (NRT) products, which are part of Euromonitor's Passport Consumer Healthcare database.

See All of Our Definitions


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!